Hospital Mater Dei (MATD3) investor relations material

Executive summary

• Achieved record net revenue of BRL 546 million in Q2 2025, with all-time high operational and financial indicators, driven by improved procedure mix, disciplined management, and strong performance across all hubs.

• Inaugurated Mariana Medical Center in partnership with Vale, expanding regional presence and service accessibility.

• Maintained high occupancy rates, reaching 83% in Q2 2025, reflecting operational rigor and maturity.

• Achieved reaccreditation for key units (JCI, QMENTUM) and published the 2024 Sustainability Report, highlighting ESG progress.

• Network-wide NPS reached 73, with some units exceeding 80, indicating strong patient satisfaction and record-high monthly NPS in June 2025.

Financial highlights

• Net revenue reached BRL 546 million, up 12% year-over-year, with EBITDA of BRL 115–150 million and margin at 21.1%.

• Net income was BRL 27–40 million, up 67% year-over-year, with net margin at 5–8.2%.

• Cost of services provided was 69.8% of net revenue, with operational expenses diluted to 14.1%.

• Net debt reduced to BRL 772 million, leverage ratio improved to 1.6x, and cash and equivalents stood at BRL 638 million.

• CapEx and dividend payments tightly controlled, with no significant increase expected in the second half of the year.

Outlook and guidance

• Expect continued EBITDA growth and operational efficiency in the second half of 2025, with focus on expanding complex procedures and digitalization.

• Plans to prepay BRL 200 million in debt, consider further investments or stock buybacks, and maintain financial discipline.

• Debt maturities extended to 2031/2032, reinforcing long-term financial sustainability.